Cause-specific mortality adjudication in the UPLIFT ® COPD trial: Findings and recommendations

Respiratory Medicine

Volumn 106, Issue 4, 2012, Pages 515-521

  McGarvey, Lorcan P ^a   Magder, Sheldon ^b   Burkhart, Deborah ^c   Kesten, Steven ^c   Liu, Dacheng ^c   Manuel, Raymond C ^c   Niewoehner, Denis E ^d  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cause of death; Independent; Tiotropium; UPLIFT

Indexed keywords

TIOTROPIUM BROMIDE;

ACUTE HEART FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CANCER; CONGESTIVE HEART FAILURE; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG FATALITY; EMPHYSEMA; FEMALE; GASTROINTESTINAL DISEASE; HEART ARREST; HEART DEATH; HEART INFARCTION; HUMAN; INTOXICATION; LUNG CARCINOMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY ADJUDICATION; MULTICENTER STUDY (TOPIC); MULTIPLE ORGAN FAILURE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPTIC SHOCK; SUDDEN DEATH;

AGED; BRONCHODILATOR AGENTS; CAUSE OF DEATH; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SCOPOLAMINE DERIVATIVES; VITAL CAPACITY;

EID: 84857924286     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.10.009     Document Type: Article

References (20)

1. A.L. Hansell, J.A. Walk, and J.B. Soriano What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis Eur Respir J 22 2003 809 814 (Pubitemid 37369571)
2. H.H. Jensen, N.S. Godtfredsen, P. Lange, and J. Vestbo Potential misclassification of causes of death from COPD Eur Respir J 28 2006 781 785 (Pubitemid 46331999)
3. M.B. Drummond, R.A. Wise, M. John, M.T. Zvarich, and L.P. McGarvey Accuracy of death certificates in COPD: analysis from the TORCH trial COPD 7 2010 179 185
4. S.D. Solomon, D. Wang, P. Finn, H. Skali, L. Zornoff, and J.J. McMurray Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 110 2004 2180 2183 (Pubitemid 39372498)
5. K.W. Mahaffey, M.T. Roe, C.K. Dyke, L.K. Newby, N.S. Kleiman, and P. Connolly Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary Syndrome events in a global Organization Network trial Am Heart J 143 2002 242 248
6. C.B. Granger, V. Vogel, S.R. Cummings, P. Held, F. Fiedorek, and M. Lawrence Do we need to adjudicate major clinical events? Clin Trials 5 2008 56 60 (Pubitemid 351412373)
7. J. Zielinski, W. MacNee, J. Wedzicha, N. Ambrosino, A. Braghiroli, and J. Dolensky Causes of death in patients with COPD and chronic respiratory failure Monaldi Arch Chest Dis 52 1997 43 47 (Pubitemid 27232210)
8. N.R. Anthonisen, J.E. Connett, J.P. Kiley, M.D. Altose, W.C. Bailey, and A.S. Buist Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 272 1994 1497 1505
9. L.P. McGarvey, M. John, J.A. Anderson, M. Zvarich, and R.A. Wise TORCH clinical endpoint committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical endpoint committee Thorax 62 2007 411 415 (Pubitemid 46698390)
10. M. Decramer, B. Celli, D.P. Tashkin, R.A. Pauwels, D. Burkhart, and C. Cassino Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial COPD 1 2004 303 312
11. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, and S. Menjoge UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
12. B. Celli, M. Decramer, S. Kesten, D. Liu, S. Mehra, and D.P. Tashkin UPLIFT Study Investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 180 2009 948 955
13. N.R. Anthonisen, J.E. Connett, P.L. Enright, and J. Manfreda Lung health study research group. Hospitalizations and mortality in the lung health study Am J Respir Crit Care Med 166 2002 333 339 (Pubitemid 34864422)
14. W.T. McNicholas, and M.X. Fitzgerald Nocturnal deaths among patients with chronic bronchitis and emphysema Br Med J (Clin Res Ed) 289 1984 878 (Pubitemid 14006113)
15. D. Mozaffarian, S.D. Anker, and I. Anand Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 2007 392 398 (Pubitemid 47196544)
16. C.M. Albert, C.H. Hennekens, C.J. O'Donnell, U.A. Ajani, V.J. Carey, and W.C. Willett Fish consumption and risk of sudden cardiac death JAMA 279 1998 23 28 (Pubitemid 28070546)
17. M.I. Restrepo, E.M. Mortensen, J.A. Pugh, and A. Anzueto COPD is associated with increased mortality in patients with community-acquired pneumonia Eur Respir J 28 2006 346 351 (Pubitemid 44914234)
18. S. Singh, and Y.K. Loke Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update Curr Opin Pulm Med 16 2010 118 122
19. A. Heagerty, A. Deverly, C. Palmer, E. Kaplinsky, A. Salvetti, and N.G. Wahlgren The role of the critical event committee in a major cardiovascular outcome study Blood Press 11 2002 339 344 (Pubitemid 36061178)
20. U. Näslund, L. Grip, J. Fischer-Hansen, T. Gundersen, S. Lehto, and L. Wallentin The impact of an end-point committee in a large multicentre, randomised, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points Eur Heart J 20 1999 771 777 (Pubitemid 29209911)